ENXTPA:EAPIPharmaceuticals
Here's What Euroapi S.A.'s (EPA:EAPI) Shareholder Ownership Structure Looks Like
A look at the shareholders of Euroapi S.A. ( EPA:EAPI ) can tell us which group is most powerful. Large companies...
ENXTPA:VIRPPharmaceuticals
An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Virbac SA ( EPA:VIRP...
ENXTPA:SANPharmaceuticals
The total return for Sanofi (EPA:SAN) investors has risen faster than earnings growth over the last three years
By buying an index fund, investors can approximate the average market return. But if you choose individual stocks with...
ENXTPA:IPNPharmaceuticals
Does Ipsen (EPA:IPN) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
ENXTPA:VIRPPharmaceuticals
Virbac (EPA:VIRP) sheds 5.6% this week, as yearly returns fall more in line with earnings growth
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...
ENXTPA:VETOPharmaceuticals
Do Vetoquinol's (EPA:VETO) Earnings Warrant Your Attention?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
ENXTPA:IPNPharmaceuticals
Here's Why We Think Ipsen (EPA:IPN) Might Deserve Your Attention Today
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
ENXTPA:SANPharmaceuticals
Are Sanofi's (EPA:SAN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
It is hard to get excited after looking at Sanofi's (EPA:SAN) recent performance, when its stock has declined 6.5% over...
ENXTPA:BOIPharmaceuticals
Boiron SA's (EPA:BOI) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
Boiron (EPA:BOI) has had a great run on the share market with its stock up by a significant 18% over the last three...